IN2014MN01706A - - Google Patents

Info

Publication number
IN2014MN01706A
IN2014MN01706A IN1706MUN2014A IN2014MN01706A IN 2014MN01706 A IN2014MN01706 A IN 2014MN01706A IN 1706MUN2014 A IN1706MUN2014 A IN 1706MUN2014A IN 2014MN01706 A IN2014MN01706 A IN 2014MN01706A
Authority
IN
India
Prior art keywords
bitter taste
active ingredient
fast dissolving
film composition
dissolving film
Prior art date
Application number
Other languages
English (en)
Inventor
Hyun Jun Jeong
Ik Hyeon Chang
Dal Geun Kim
Jin Hoo Lee
Jin Hee Um
Hyun Soo Kim
Kyung Tae Jung
Kyu Jeong Yeon
Jin Gyu Park
Original Assignee
Seoul Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020120020316A external-priority patent/KR101328350B1/ko
Priority claimed from KR1020120117233A external-priority patent/KR101440808B1/ko
Application filed by Seoul Pharma Co Ltd filed Critical Seoul Pharma Co Ltd
Publication of IN2014MN01706A publication Critical patent/IN2014MN01706A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN1706MUN2014 2012-02-28 2013-02-28 IN2014MN01706A (sh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020120020316A KR101328350B1 (ko) 2012-02-28 2012-02-28 실데나필 또는 이의 약제학적으로 허용되는 염을 유효성분으로 함유하는 고미가 은폐된 약제학적 조성물
KR1020120117233A KR101440808B1 (ko) 2012-10-22 2012-10-22 실데나필 또는 이의 약제학적으로 허용되는 염을 고함량으로 포함하는 속용필름
PCT/KR2013/001679 WO2013129889A2 (ko) 2012-02-28 2013-02-28 실데나필을 유효성분으로 함유하며 고미가 은폐된 고함량 속용필름

Publications (1)

Publication Number Publication Date
IN2014MN01706A true IN2014MN01706A (sh) 2015-05-29

Family

ID=49083410

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1706MUN2014 IN2014MN01706A (sh) 2012-02-28 2013-02-28

Country Status (7)

Country Link
US (1) US10092651B2 (sh)
EP (1) EP2821066B1 (sh)
JP (1) JP5941558B2 (sh)
CN (1) CN104168895B (sh)
CA (1) CA2864322C (sh)
IN (1) IN2014MN01706A (sh)
WO (1) WO2013129889A2 (sh)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103989661B (zh) * 2014-05-26 2016-04-20 苏州大学 西地那非口腔速溶膜剂及其制备方法
KR101538985B1 (ko) * 2014-09-02 2015-07-24 주식회사 서울제약 타다라필 구강붕해필름 및 이의 제조방법
JP2017537127A (ja) * 2014-12-09 2017-12-14 モノソル アールエックス リミテッド ライアビリティ カンパニー 線状多糖をベースとするフィルム製品
CN104586820B (zh) * 2015-01-13 2021-04-09 齐鲁制药有限公司 具有高载药量的西地那非口腔速溶薄膜组合物
CN104546807B (zh) * 2015-01-21 2020-09-01 齐鲁制药有限公司 奥氮平口腔速溶膜剂
US20180028662A1 (en) 2015-02-25 2018-02-01 Eisai R&D Management Co., Ltd. Method for Suppressing Bitterness of Quinoline Derivative
US20210322537A1 (en) * 2016-06-07 2021-10-21 Aridis Pharmaceuticals, Inc. Method For Preparation of Quick Dissolving Thin Films Containing Bioactive Material With Enhanced Thermal Stability
WO2018166432A1 (en) * 2017-03-13 2018-09-20 Nano And Advanced Materials Institute Limited High loading and fast disintegration film for fast drug absorption
CN106860404A (zh) * 2017-04-13 2017-06-20 中国药科大学 一种枸橼酸西地那非掩味树脂复合物及其应用
CN109717282A (zh) * 2017-10-30 2019-05-07 上海冠生园食品有限公司 一种富含花青素的糖果及其制备方法
WO2019161322A1 (en) * 2018-02-19 2019-08-22 Monell Chemical Senses Center Compositions and methods of ameliorating pharmaceutical aversiveness with salts
CN109010324B (zh) * 2018-08-30 2021-07-02 南京康川济医药科技有限公司 一种西地那非口溶膜剂及其制备方法
CN111466564A (zh) * 2019-01-24 2020-07-31 甄崇礼 含有天然活性多糖的口腔速溶膜剂及其制备方法
CN110128429A (zh) * 2019-04-30 2019-08-16 孙常全 一种西地那非-安赛蜜盐型及其制备方法和用途
US11179331B1 (en) 2020-04-21 2021-11-23 Cure Pharmaceutcai Holding Corp Oral soluble film containing sildenafil citrate
GR20200100430A (el) * 2020-06-01 2022-01-13 Κυριακος Ηλια Κυπραιος Ταχεως διαλυομενες στοματικες ταινιες για τη χορηγηση δια της στοματικης οδου φαρμακων και λοιπων βιοδραστικων ουσιων σε ανθρωπους
WO2022139863A1 (en) * 2020-12-22 2022-06-30 Solugen, Inc. Bitter masking agent
CN115252587A (zh) * 2022-08-19 2022-11-01 南京泛太化工医药研究所 一种口腔速溶膜及其制备方法
CN116270553B (zh) * 2023-02-01 2024-05-07 北京悦康科创医药科技股份有限公司 一种爱地那非口溶膜剂及其制备方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US652024A (en) 1898-12-08 1900-06-19 James Gray Valve mechanism for automatic water-heaters.
TW271400B (sh) * 1992-07-30 1996-03-01 Pfizer
GB9311920D0 (en) 1993-06-09 1993-07-28 Pfizer Ltd Therapeutic agents
GB9401090D0 (en) 1994-01-21 1994-03-16 Glaxo Lab Sa Chemical compounds
US5605889A (en) 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin
UA46166C2 (uk) 1997-11-12 2002-05-15 Баєр Акцієнгезельшафт 2-фенілзаміщені імідазотриазинони як інгібітори фосфодіестерази, спосіб їх одержання та лікарський засіб на їх основі
KR100353014B1 (ko) 1998-11-11 2002-09-18 동아제약 주식회사 발기부전 치료에 효과를 갖는 피라졸로피리미디논 화합물
US6552024B1 (en) 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
US7067116B1 (en) 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
AU2001273545A1 (en) * 2000-07-19 2002-01-30 Lavipharm Laboratories, Inc. Sildenafil citrate solid dispersions having high water solubility
DE10207394B4 (de) 2002-02-21 2007-03-29 Lts Lohmann Therapie-Systeme Ag Geschmacksmaskierte oblatenförmige Arzneizubereitung
GB0219516D0 (en) * 2002-08-21 2002-10-02 Phoqus Ltd Fast dissolving and taste masked oral dosage form comprising sildenafil
KR20060031552A (ko) 2004-10-08 2006-04-12 박영국 취수선을 이용한 해양 심층수 취수 방법
US20070092553A1 (en) 2005-10-21 2007-04-26 Pfab Lp Compositions and methods of making rapidly dissolving lonically masked formulations
AU2006317530B2 (en) * 2005-11-28 2011-09-01 Imaginot Pty Ltd Oral therapeutic compound delivery system
WO2007109057A2 (en) * 2006-03-16 2007-09-27 Novartis Ag Solid dosage form containing a taste masked active agent
KR101304343B1 (ko) 2006-04-06 2013-09-11 한미사이언스 주식회사 Ｐｄｅ-5 억제제의 경구용 속용제형
PL2248519T3 (pl) 2006-10-02 2018-04-30 Apr Applied Pharma Research S.A. Niemukoadhezyjne postaci dawkowania w postaci filmu
AU2008206362A1 (en) 2007-01-12 2008-07-24 Monosol Rx Llc High dose film compositions and methods of preparation
US20080220029A1 (en) 2007-03-05 2008-09-11 Charlene Ng Fast-dissolving/disintegrating film preparation having high proportion of active
US20090047330A1 (en) * 2007-08-17 2009-02-19 Ramesh Bangalore Oral fast dissolving films for erectile dysfunction bioactive agents
US20100297232A1 (en) * 2009-05-19 2010-11-25 Monosol Rx, Llc Ondansetron film compositions
KR101074271B1 (ko) 2009-06-25 2011-10-17 (주)차바이오앤디오스텍 불쾌한 맛을 효과적으로 은폐한 경구용 속용 필름
DE102010049708A1 (de) * 2010-10-28 2012-05-03 Hexal Ag Orale pharmazeutische Filmformulierung für bitter schmeckende Arzneistoffe
CN103402504B (zh) * 2011-02-11 2015-10-14 西梯茜生命工学股份有限公司 包含西地那非游离碱的膜制剂及其生产方法
KR101188594B1 (ko) 2011-12-06 2012-10-08 (주)씨엘팜 쓴맛이 차단된 실데나필 시트르산의 구강내 속붕해 필름제형

Also Published As

Publication number Publication date
EP2821066A4 (en) 2015-10-21
CN104168895B (zh) 2020-02-21
CN104168895A (zh) 2014-11-26
WO2013129889A3 (ko) 2013-10-24
CA2864322A1 (en) 2013-09-06
US20150025084A1 (en) 2015-01-22
JP5941558B2 (ja) 2016-06-29
EP2821066B1 (en) 2018-04-25
EP2821066A2 (en) 2015-01-07
US10092651B2 (en) 2018-10-09
WO2013129889A2 (ko) 2013-09-06
CA2864322C (en) 2016-08-09
WO2013129889A9 (ko) 2014-10-16
JP2015504916A (ja) 2015-02-16

Similar Documents

Publication Publication Date Title
IN2014MN01706A (sh)
MX2019005379A (es) Derivado de pirazolo-heteroarilo, metodo de preparacion y uso medico del mismo.
MX2019007956A (es) Liberacion autorregulada de ingrediente farmaceutico activo.
SG10201810985XA (en) Tofacitinib oral sustained release dosage forms
MX2015010971A (es) Derivado novedoso de pirazol.
IN2014MN01755A (sh)
EA201690102A1 (ru) Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе
MY197785A (en) Combinations of lsd1 inhibitors for the treatment of hematological malignancies
NZ631100A (en) Soft chewable pharmaceutical products
MY180145A (en) Cenicriviroc compositions and methods of making and using the same
IN2013MU03583A (sh)
NZ720328A (en) Pyranochromenyl phenol derivative, and pharmaceutical composition for treating metabolic syndrome or inflammatory disease
MY157673A (en) Pharmaceutical compositions comprising hydromorphone and naloxone
EP3162804A8 (en) New benzodiazepine derivative and use thereof
PH12014501545A1 (en) Stable pharmaceutical formulation for oral administration comprising levocetirizine or a pharmaceutically acceptable salt thereof, and montelukast or a pharmaceutically acceptable salt thereof
MD3482754T2 (ro) Compoziții farmaceutice și utilizări direcționate spre tulburări de stocare lizozomale
PH12015500653B1 (en) Combination drug comprising gemigliptin and metformin, and method for the preparation thereof
MX2023012198A (es) Composiciones de amantadina, preparaciones de estas y metodos de uso.
WO2011093815A3 (en) Pharmaceutical compositions comprising formoterol and mometasone
WO2011093818A3 (en) Pharmaceutical compositions comprising salmeterol and fluticasone
WO2014122460A3 (en) Pemetrexed complexes and pharmaceutical compositions containing pemetrexed complexes
MX2015007731A (es) Formulacion farmaceutica que comprende ciclesonida.
GEP20196957B (en) Crystalline forms of s-acetyl glutathione, their reparations and uses in pharmaceutical and nutraceutical formulations
WO2014007549A3 (ko) 에스-알릴-엘-시스테인을 유효성분으로 포함하는 대장염 예방 또는 치료용 조성물 및 이를 포함하는 의약제제
IN2014DN10134A (sh)